Literature DB >> 2452954

Acute phase proteins and liver allograft rejection.

C P Maury1, A M Teppo, K Höckerstedt.   

Abstract

We studied the sequential changes in the positive acute phase reactants orosomucoid, alpha 1-antichymotrypsin, alpha 1-antitrypsin, haptoglobin and C-reactive protein, and in the negative acute phase reactant, prealbumin, as well as in alpha 2-macroglobulin and beta 2-microglobulin in serum following orthotopic liver transplantation in nine adult patients. Synchronous increases in all five positive acute phase reactants were observed in association with acute liver rejection episodes; the elevations were statistically significant for orosomucoid and alpha 1-antichymotrypsin. In four out of nine well-documented rejection episodes C-reactive protein did not increase at all. Marked variations occurred in post-transplant prealbumin and alpha 2-macroglobulin levels; both proteins tended to decrease 2-3 days after the rejection was diagnosed. The circulating levels of beta 2-microglobulin were raised during the post-transplant period and markedly increased in association with acute graft rejection episodes. The results demonstrate marked changes in plasma protein concentrations in association with acute liver allograft rejection episodes; the kinetics of serum acute phase reactants is very similar to that found in inflammation and tissue injury in general.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452954     DOI: 10.1111/j.1600-0676.1988.tb00971.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  2 in total

1.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Identification of differentially expressed genes after partial rat liver ischemia/reperfusion by suppression subtractive hybridization.

Authors:  Christine Fallsehr; Christina Zapletal; Michael Kremer; Resit Demir; Magnus von Knebel Doeberitz; Ernst Klar
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.